Showing results (2281-2290 of 4,062) with videos related to

Sort By:
Pageof 407
Current Medical Research and Opinion|April 27, 1999
Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study GroupJ A Diamond, A Gharavi, D Roychoudhury, et al.
Chest|August 1, 1990
Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSAB A Phillips, F A Schmitt, D T Berry, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1990
Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidusD R Repaske, J A Phillips, L T Kirby, et al.
Computers in Biology and Medicine|January 23, 1998
Microprocessor based spatial TENS (transcutaneous electric nerve stimulator) designed with waveform optimality for clinical evaluation in a pain studyD W Repperger, C C Ho, P Aukuthota, et al.
The American Journal of Medicine|May 1, 1980
Liver cysts in patients with autosomal dominant polycystic kidney diseaseJ Milutinovic, P J Fialkow, T G Rudd, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
Identification of lumichrome as a sinorhizobium enhancer of alfalfa root respiration and shoot growthD A Phillips, C M Joseph, G P Yang, et al.
Bioscience Reports|December 6, 2016
Assessing the subcellular distribution of oncogenic phosphoinositide 3-kinase using microinjection into live cellsMeredith J Layton, Natalie K Rynkiewicz, Ivan Ivetac, et al.
BMC Bioinformatics|April 16, 2014
On finding bicliques in bipartite graphs: a novel algorithm and its application to the integration of diverse biological data typesYun Zhang, Charles A Phillips, Gary L Rogers, et al.
Biochemical Pharmacology|May 11, 1995
Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B"C A Campen, M T Lai, P Kraft, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the ratL M Burrell, P A Phillips, J M Stephenson, et al.
Pageof 407